For 3/5 of the CTX drugs, there was a significant inverse correlation between the sensitivity of the cancer cells to the drug (expressed as the mean 50% growth inhibitory concentration, GI50) and PTGS2 induction (Fig. 4e, f, Supplementary Fig. 6a, b). This evidence concerns the gene PTGS2 and cancer.